Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Medicine (Baltimore). 2010 Nov;89(6):403–425. doi: 10.1097/MD.0b013e3181fd8ec3

Figure 6.

Figure 6

Percentage of clinical manifestations found in each patient: in MyD88-deficient patients, in IRAK-4-deficient patients, and in all patients. (ENT = ear, nose, and throat.)